XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Follow-On Public Offering
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Follow-On Public Offering
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Jun. 30, 2023 $ 341,208   $ 69 $ 797,639   $ (1,339) $ (455,161)
Beginning Balance, shares at Jun. 30, 2023     68,574        
Issuance of common stock upon exercise of stock options 17,936   $ 2 17,934      
Issuance of common stock upon exercise of stock options, shares     1,641        
Vesting of performance stock units and restricted stock units     $ 1 (1)      
Vesting of performance stock units and restricted stock units, shares     1,645        
Issuance of common stock under employee stock purchase plan 1,725     1,725      
Issuance of common stock under employee stock purchase plan, shares     81        
Stock-based compensation 35,265     35,265      
Issuance of common stock, net of offering costs of $1,569   $ (4)     $ (4)    
Foreign currency translation adjustments 61         61  
Net loss (24,534)           (24,534)
Ending Balance at Dec. 31, 2023 371,657   $ 72 852,558   (1,278) (479,695)
Ending Balance, shares at Dec. 31, 2023     71,941        
Beginning Balance at Sep. 30, 2023 346,673   $ 69 818,716   (1,630) (470,482)
Beginning Balance, shares at Sep. 30, 2023     69,378        
Issuance of common stock upon exercise of stock options 15,612   $ 2 15,610      
Issuance of common stock upon exercise of stock options, shares     1,412        
Vesting of performance stock units and restricted stock units     $ 1 (1)      
Vesting of performance stock units and restricted stock units, shares     1,070        
Issuance of common stock under employee stock purchase plan 1,725     1,725      
Issuance of common stock under employee stock purchase plan, shares     81        
Stock-based compensation 16,508     16,508      
Foreign currency translation adjustments 352         352  
Net loss (9,213)           (9,213)
Ending Balance at Dec. 31, 2023 371,657   $ 72 852,558   (1,278) (479,695)
Ending Balance, shares at Dec. 31, 2023     71,941        
Beginning Balance at Jun. 30, 2024 403,238   $ 75 891,681   (1,336) (487,182)
Beginning Balance, shares at Jun. 30, 2024     74,624        
Issuance of common stock upon exercise of stock options $ 32,584   $ 3 32,581      
Issuance of common stock upon exercise of stock options, shares 3,161   3,161        
Vesting of performance stock units and restricted stock units     $ 1 (1)      
Vesting of performance stock units and restricted stock units, shares     1,382        
Issuance of common stock under employee stock purchase plan $ 1,970     1,970      
Issuance of common stock under employee stock purchase plan, shares     67        
Stock-based compensation 45,400     45,400      
Foreign currency translation adjustments (65)         (65)  
Net loss (14,737)           (14,737)
Ending Balance at Dec. 31, 2024 468,390   $ 79 971,631   (1,401) (501,919)
Ending Balance, shares at Dec. 31, 2024     79,234        
Beginning Balance at Sep. 30, 2024 442,120   $ 78 934,585   (841) (491,702)
Beginning Balance, shares at Sep. 30, 2024     77,285        
Issuance of common stock upon exercise of stock options 9,666   $ 1 9,665      
Issuance of common stock upon exercise of stock options, shares     1,123        
Vesting of performance stock units and restricted stock units, shares     759        
Issuance of common stock under employee stock purchase plan 1,970     1,970      
Issuance of common stock under employee stock purchase plan, shares     67        
Stock-based compensation 25,411     25,411      
Foreign currency translation adjustments (560)         (560)  
Net loss (10,217)           (10,217)
Ending Balance at Dec. 31, 2024 $ 468,390   $ 79 $ 971,631   $ (1,401) $ (501,919)
Ending Balance, shares at Dec. 31, 2024     79,234